• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CA19-9/TBIL比值在胆道癌(BTCs)患者中的预后价值:一项回顾性研究

The Prognostic Value of the CA19-9/TBIL Ratio in Patients with Biliary Tract Cancers (BTCs): A Retrospective Study.

作者信息

Xiao Jianchun, Wang Li, Hong Tao, Li Binglu, Liu Wei, Qu Qiang, Zheng Chaoji, He Xiaodong

机构信息

Department of General Surgery, Peking Union Medical College Hospital, Beijing 100730, China.

出版信息

J Oncol. 2021 Feb 23;2021:5829893. doi: 10.1155/2021/5829893. eCollection 2021.

DOI:10.1155/2021/5829893
PMID:33688345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7925024/
Abstract

BACKGROUND

Incidence of biliary tract cancers (BTCs) in China is high, and surgery is the only curative option. Preoperative CA19-9 has been identified as a predictor for survival in patients with resectable BTCs, but more potential predictors need to be studied. This retrospective study aimed to establish the prognostic significance of CA19-9/TBIL ratio (CTR) in patients with BTCs.

METHODS

A retrospective analysis was performed in patients who were diagnosed with BTCs and received surgical resection between 2013 and 2018 at PUMCH. Demographic and clinical parameters were collected. Preoperative CA19-9 and CTR were classified as elevated (>58.6 and >0.83) according to the receiver operating characteristic (ROC) analysis. Demographic and clinical parameters were compared between the groups using Student's -test, chi-square, or Fisher's exact test. Survival analysis was performed by the Kaplan-Meier methods, and the relationship between variables and survival was assessed by the log-rank test. Cox regression analysis was conducted to identify potential risk factors for overall survival.

RESULTS

In total, 109 participants were involved in the final analysis. The overall survival rate was 18.0% at 5 years, with a median survival duration of 1.58 years. The Kaplan-Meier analysis indicated that higher CTR was associated with shorter OS (15 vs. 50, < 0.01). Univariate survival analysis identified TNM staging, CA19-9, and CTR as statistically significant prognostic factors. In a multiple Cox analysis, only CTR was proved as a significantly independent prognostic factor.

CONCLUSION

CTR acts as an independent prognostic predictor for patients with biliary tract cancer.

摘要

背景

中国胆道癌(BTCs)的发病率很高,手术是唯一的治愈选择。术前CA19-9已被确定为可切除BTCs患者生存的预测指标,但仍需研究更多潜在的预测指标。这项回顾性研究旨在确定CA19-9/总胆红素比值(CTR)在BTCs患者中的预后意义。

方法

对2013年至2018年期间在北京协和医院被诊断为BTCs并接受手术切除的患者进行回顾性分析。收集人口统计学和临床参数。根据受试者工作特征(ROC)分析,将术前CA19-9和CTR分类为升高(>58.6和>0.83)。使用Student's -检验、卡方检验或Fisher精确检验对各组之间的人口统计学和临床参数进行比较。采用Kaplan-Meier方法进行生存分析,并通过对数秩检验评估变量与生存之间的关系。进行Cox回归分析以确定总生存的潜在危险因素。

结果

共有109名参与者纳入最终分析。5年总生存率为18.0%,中位生存时间为1.58年。Kaplan-Meier分析表明,较高的CTR与较短的总生存期相关(15对50,<0.01)。单因素生存分析确定TNM分期、CA19-9和CTR为具有统计学意义的预后因素。在多因素Cox分析中,只有CTR被证明是一个显著的独立预后因素。

结论

CTR是胆道癌患者的独立预后预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9f2/7925024/d494638a75be/JO2021-5829893.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9f2/7925024/4b3ab072c132/JO2021-5829893.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9f2/7925024/1309ceaef27d/JO2021-5829893.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9f2/7925024/d494638a75be/JO2021-5829893.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9f2/7925024/4b3ab072c132/JO2021-5829893.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9f2/7925024/1309ceaef27d/JO2021-5829893.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9f2/7925024/d494638a75be/JO2021-5829893.003.jpg

相似文献

1
The Prognostic Value of the CA19-9/TBIL Ratio in Patients with Biliary Tract Cancers (BTCs): A Retrospective Study.CA19-9/TBIL比值在胆道癌(BTCs)患者中的预后价值:一项回顾性研究
J Oncol. 2021 Feb 23;2021:5829893. doi: 10.1155/2021/5829893. eCollection 2021.
2
The predictive value of systemic immune inflammation index for postoperative survival of gallbladder carcinoma patients.全身免疫炎症指数对胆囊癌患者术后生存的预测价值。
J Surg Oncol. 2021 Jul;124(1):59-66. doi: 10.1002/jso.26470. Epub 2021 Mar 25.
3
[Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].[术前外周血淋巴细胞与单核细胞比值对Ⅲ期结肠癌患者预后的评估价值]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Jan 25;22(1):73-78.
4
The Prognostic Value of Combination of Plasma Fibrinogen and CA19-9 in Non-Distant Metastatic Breast Cancer Patients Undergoing Surgery.血浆纤维蛋白原与CA19-9联合检测对接受手术的非远处转移性乳腺癌患者的预后价值
Cancer Manag Res. 2020 Sep 23;12:8875-8886. doi: 10.2147/CMAR.S270385. eCollection 2020.
5
Prognostic impact of the ratio of preoperative CA19-9 to liver enzyme levels in pancreatic cancer patients with jaundice (predictability of combined CA19-9/AST and CA19-9/γ-GGT for jaundiced PDAC patients).黄疸型胰腺癌患者术前CA19-9与肝酶水平比值的预后影响(联合CA19-9/AST及CA19-9/γ-GGT对黄疸型胰腺导管腺癌患者的预测价值)
Pancreatology. 2021 Sep;21(6):1092-1101. doi: 10.1016/j.pan.2021.05.300. Epub 2021 May 26.
6
Perineural invasion and preoperative serum CA19-9 as predictors of survival in biliary tract cancer.神经周围侵犯和术前血清 CA19-9 可预测胆道癌的生存情况。
Anticancer Res. 2013 Feb;33(2):583-94.
7
Preoperative Alkaline Phosphatase-adjusted CA19-9 as a Superior Prognosticator for Extrahepatic Biliary Tract Cancer With Jaundice.术前碱性磷酸酶校正的CA19-9作为黄疸型肝外胆管癌的优越预后指标。
Cancer Diagn Progn. 2022 Sep 3;2(5):569-575. doi: 10.21873/cdp.10144. eCollection 2022 Sep-Oct.
8
Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study.血清CA19-9水平升高是可切除性胰腺导管腺癌患者预后不良的一个有前景的预测指标:一项初步研究。
World J Surg Oncol. 2014 Jun 2;12:171. doi: 10.1186/1477-7819-12-171.
9
Elevated CA 19-9 portends poor prognosis in patients undergoing resection of biliary malignancies.CA 19-9 升高预示着接受胆道恶性肿瘤切除术的患者预后不良。
HPB (Oxford). 2010 Mar;12(2):134-8. doi: 10.1111/j.1477-2574.2009.00149.x.
10
Prognostic significance of neutrophil-lymphocyte ratio and carbohydrate antigen 19-9 in patients with gallbladder carcinoma.中性粒细胞与淋巴细胞比值及糖类抗原19-9在胆囊癌患者中的预后意义
Medicine (Baltimore). 2019 Feb;98(8):e14550. doi: 10.1097/MD.0000000000014550.

引用本文的文献

1
CA19-9/DBil: a promising indicator to distinguish between CA19-9-elevated pancreatic head-type autoimmune pancreatitis and pancreatic head cancer.CA19-9/总胆红素:区分CA19-9升高的胰头型自身免疫性胰腺炎与胰头癌的一个有前景的指标。
BMC Gastroenterol. 2025 Apr 29;25(1):306. doi: 10.1186/s12876-025-03925-9.
2
The Association Between Brominated Flame Retardants Exposure and Liver-Related Biomarkers in US Adults.美国成年人中溴化阻燃剂暴露与肝脏相关生物标志物之间的关联。
Toxics. 2024 Nov 26;12(12):852. doi: 10.3390/toxics12120852.
3
Preoperative Alkaline Phosphatase-adjusted CA19-9 as a Superior Prognosticator for Extrahepatic Biliary Tract Cancer With Jaundice.

本文引用的文献

1
Clinical significance of preoperative CA19-9 and lymph node metastasis in intrahepatic cholangiocarcinoma.术前 CA19-9 与肝内胆管癌淋巴结转移的临床意义。
Surg Today. 2020 Oct;50(10):1176-1186. doi: 10.1007/s00595-020-01992-x. Epub 2020 Mar 27.
2
Prognostic significance of and risk prediction model for lymph node metastasis in resectable intrahepatic cholangiocarcinoma: do all require lymph node dissection?可切除性肝内胆管细胞癌中淋巴结转移的预后意义和风险预测模型:是否都需要淋巴结清扫?
HPB (Oxford). 2020 Oct;22(10):1411-1419. doi: 10.1016/j.hpb.2020.01.009. Epub 2020 Feb 8.
3
Novel staging system using carbohydrate antigen (CA) 19-9 in extra-hepatic cholangiocarcinoma and its implications on overall survival.
术前碱性磷酸酶校正的CA19-9作为黄疸型肝外胆管癌的优越预后指标。
Cancer Diagn Progn. 2022 Sep 3;2(5):569-575. doi: 10.21873/cdp.10144. eCollection 2022 Sep-Oct.
新型胆外胆管癌糖类抗原(CA)19-9 分期系统及其对总生存期的影响。
Eur J Surg Oncol. 2020 May;46(5):789-795. doi: 10.1016/j.ejso.2020.01.016. Epub 2020 Jan 11.
4
Prognostic Value and Predication Model of Microvascular Invasion in Patients with Intrahepatic Cholangiocarcinoma.肝内胆管癌患者微血管侵犯的预后价值及预测模型
J Cancer. 2019 Sep 7;10(22):5575-5584. doi: 10.7150/jca.32199. eCollection 2019.
5
Biliary tract cancers: current knowledge, clinical candidates and future challenges.胆道癌:当前认知、临床候选因素及未来挑战
Cancer Manag Res. 2019 Mar 29;11:2623-2642. doi: 10.2147/CMAR.S157092. eCollection 2019.
6
Prognostic relevance of preoperative bilirubin-adjusted serum carbohydrate antigen 19-9 in a multicenter subset analysis of 179 patients with distal cholangiocarcinoma.术前胆红素校正的血清碳水化合物抗原 19-9 在 179 例远端胆管癌多中心亚组分析中的预后相关性。
HPB (Oxford). 2019 Nov;21(11):1513-1519. doi: 10.1016/j.hpb.2019.03.363. Epub 2019 Apr 5.
7
New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer.关于 CA19-9 作为 Lewis 阴性胰腺癌患者生物标志物的效用的新观察。
Pancreatology. 2018 Dec;18(8):971-976. doi: 10.1016/j.pan.2018.08.003. Epub 2018 Aug 9.
8
Differential diagnostic roles of the serum CA19-9, total bilirubin (TBIL) and the ratio of CA19-9 to TBIL for benign and malignant.血清CA19-9、总胆红素(TBIL)及CA19-9与TBIL比值在良恶性疾病中的鉴别诊断作用。
J Cancer. 2018 Apr 19;9(10):1804-1812. doi: 10.7150/jca.25093. eCollection 2018.
9
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma.CEA 而非 CA19-9 是接受胆管癌切除术患者的独立预后因素。
Sci Rep. 2017 Dec 5;7(1):16975. doi: 10.1038/s41598-017-17175-7.
10
Clinical epidemiological survey of gallbladder carcinoma in northwestern China, 2009-2013: 2379 cases in 17 centers.2009 - 2013年中国西北地区胆囊癌临床流行病学调查:17个中心的2379例病例
Chronic Dis Transl Med. 2017 Feb 22;3(1):60-66. doi: 10.1016/j.cdtm.2017.01.003. eCollection 2017 Mar 25.